181 related articles for article (PubMed ID: 31167247)
21. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
López MF; Mingot ME; Valcárcel D; Vicente García V; Perrin A; Campos Tapias I
Med Clin (Barc); 2015 May; 144(9):389-96. PubMed ID: 24565604
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of immune thrombocytopenia in childhood.
Kühne T
Hamostaseologie; 2017 Jan; 37(1):36-44. PubMed ID: 27699328
[TBL] [Abstract][Full Text] [Related]
23. Clinical updates in adult immune thrombocytopenia.
Lambert MP; Gernsheimer TB
Blood; 2017 May; 129(21):2829-2835. PubMed ID: 28416506
[TBL] [Abstract][Full Text] [Related]
24. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.
Grace RF; Despotovic JM; Bennett CM; Bussel JB; Neier M; Neunert C; Crary SE; Pastore YD; Klaassen RJ; Rothman JA; Hege K; Breakey VR; Rose MJ; Shimano KA; Buchanan GR; Geddis A; Haley KM; Lorenzana A; Thompson A; Jeng M; Neufeld EJ; Brown T; Forbes PW; Lambert MP
Am J Hematol; 2018 Jul; 93(7):882-888. PubMed ID: 29659042
[TBL] [Abstract][Full Text] [Related]
25. Immune Thrombocytopenia-A Disease or a Group of Disorders? Where Do We Stand in 2019?
Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):225-226. PubMed ID: 31390662
[No Abstract] [Full Text] [Related]
26. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.
Pruemer J
Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489
[TBL] [Abstract][Full Text] [Related]
27. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
Terrell DR; Neunert CE; Cooper N; Heitink-Pollé KM; Kruse C; Imbach P; Kühne T; Ghanima W
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33266286
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin Receptor Agonist Use for Immune Thrombocytopaenia.
Neunert CE
Hamostaseologie; 2019 Aug; 39(3):272-278. PubMed ID: 30646404
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis in immune thrombocytopenia - current status and future perspectives.
Swan D; Newland A; Rodeghiero F; Thachil J
Br J Haematol; 2021 Sep; 194(5):822-834. PubMed ID: 33822358
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin receptor agonist, splenectomy and intravenous immunoglobulin for immune thrombocytopaenia with systemic lupus erythematosus.
Sofue H; Kida T; Seno T; Kohno M; Kawahito Y
Rheumatology (Oxford); 2018 Aug; 57(8):1495-1497. PubMed ID: 29579273
[No Abstract] [Full Text] [Related]
31. [Idiopathic thrombocytopenic purpura (ITP) in children].
Rajantie J
Duodecim; 2011; 127(19):2081-6. PubMed ID: 22073540
[TBL] [Abstract][Full Text] [Related]
32. Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
Hammond WA; Vishnu P; Rodriguez EM; Li Z; Dholaria B; Shreders AJ; Rivera CE
Mayo Clin Proc; 2019 Nov; 94(11):2199-2208. PubMed ID: 31685150
[TBL] [Abstract][Full Text] [Related]
33. Controversies in the treatment of immune thrombocytopenia.
Cuker A; Cines DB; Neunert CE
Curr Opin Hematol; 2016 Sep; 23(5):479-85. PubMed ID: 27380558
[TBL] [Abstract][Full Text] [Related]
34. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
35. Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.
Furudoï A; Rivière É; Lazaro E; Furudoï E; Viallard JF; Parrens M
Am J Surg Pathol; 2018 Mar; 42(3):401-412. PubMed ID: 29200102
[TBL] [Abstract][Full Text] [Related]
36. Management of immune thrombocytopenia in elderly patients.
Lucchini E; Fanin R; Cooper N; Zaja F
Eur J Intern Med; 2018 Dec; 58():70-76. PubMed ID: 30274902
[TBL] [Abstract][Full Text] [Related]
37. [Management of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia, ITP)].
Kashiwagi H; Tomiyama Y
Rinsho Ketsueki; 2014 Oct; 55(10):2087-94. PubMed ID: 25297775
[No Abstract] [Full Text] [Related]
38. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Kojouri K; George JN
Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
[TBL] [Abstract][Full Text] [Related]
39. Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
Cuker A
Am J Hematol; 2018 Jun; 93(6):816-823. PubMed ID: 29574922
[TBL] [Abstract][Full Text] [Related]
40. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
Rodrigo C; Gooneratne L
J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
